Minimal Residual Disease (MRD) refers to the small number of cancer cells that remain in a patient's body after treatment. These cells are often undetectable by traditional diagnostic methods but can cause a relapse in cancer. MRD is particularly significant in hematologic malignancies like leukemia and lymphoma. However, its relevance is increasingly recognized in solid tumors as well.
